References
- WHO. Engaging all health care providers in TB control: guidance on implementing public–private mix proposals. WHO, Geneva, Switzerland (2006).
- Sinanovic E, Kumaranayake L. Financing and cost–effectiveness analysis of public–private partnerships: provision of tuberculosis treatment in South Africa. Cost Eff. Resour. Alloc.4, 11 (2006).
- Floyd K, Arora VK, Murthy KJ et al. Cost and cost–effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bull. World Health Organ.84(6), 437–445 (2006).
- Pantoja A, Floyd K, Unnikrishnan KP et al. Economic evaluation of public–private mix for tuberculosis care and control, India. Part I. Socio–economic profile and costs among tuberculosis patients. Int. J. Tuberc. Lung Dis.13(6), 698–704 (2009).
- Pantoja A, Lönnroth K, Lal SS et al. Economic evaluation of public–private mix for tuberculosis care and control, India. Part II. Cost and cost–effectiveness. Int. J. Tuberc. Lung Dis.13(6), 705–712 (2009).
- Mahendradhata Y, Lambert ML, Boelaert M, Van der Stuyft P. Engaging the private sector for tuberculosis control: much advocacy on a meager evidence base. Trop. Med. Int. Health12(3), 315–316 (2007).
- Jack W. The public economics of tuberculosis control. Health Policy57, 79–96 (2001).
- Sutton BS, Arias MS, Chheng P, Eang MT, Kimerling ME. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia. Int. J. Tuberc. Lung Dis.13(6), 713–718 (2009).